tiprankstipranks
TYK Medicines, Inc. Class H (HK:2410)
:2410
Hong Kong Market
2410
TYK Medicines, Inc. Class H
RESEARCH TOOLSreports

TYK Medicines, Inc. Class H (2410) Stock News & Sentiment

2 Followers
TYK Medicines Narrows Annual Loss as R&D Spending Holds Steady and Governance Changes Loom
Premium
Company Announcements
TYK Medicines Narrows Annual Loss as R&D Spending Holds Steady and Governance Changes Loom
15d ago
2410
TYK Medicines to Present Five Novel Cancer Drug Programs at 2026 AACR Meeting
Premium
Company Announcements
TYK Medicines to Present Five Novel Cancer Drug Programs at 2026 AACR Meeting
20d ago
2410
TYK Medicines Completes Full H-Share Conversion to Boost Market Liquidity
Premium
Company Announcements
TYK Medicines Completes Full H-Share Conversion to Boost Market Liquidity
1M ago
2410
TYK Medicines Dilutes Stake in TYK Bio via RMB83.5 Million Capital Injection
Premium
Company Announcements
TYK Medicines Dilutes Stake in TYK Bio via RMB83.5 Million Capital Injection
2M ago
2410
TYK Medicines Wins Approval for Full H-Share Circulation in Hong Kong
Premium
Company Announcements
TYK Medicines Wins Approval for Full H-Share Circulation in Hong Kong
2M ago
2410
TYK Medicines’ Lung Cancer Drug Asandeutertinib NDA Accepted by China’s NMPA
Premium
Company Announcements
TYK Medicines’ Lung Cancer Drug Asandeutertinib NDA Accepted by China’s NMPA
2M ago
2410
TYK Medicines’ Lung Cancer Drug Asandeutertinib Granted Priority Review in China
Premium
Company Announcements
TYK Medicines’ Lung Cancer Drug Asandeutertinib Granted Priority Review in China
3M ago
2410
More HK:2410 News >

2410 News on the Web

TYK Medicines Narrows Annual Loss as R&D Spending Holds Steady and Governance Changes Loom
TipRanks News
Bearish
TYK Medicines to Present Five Novel Cancer Drug Programs at 2026 AACR Meeting
TipRanks News
Neutral
TYK Medicines Completes Full H-Share Conversion to Boost Market Liquidity
TipRanks News
Neutral
TYK Medicines Dilutes Stake in TYK Bio via RMB83.5 Million Capital Injection
TipRanks News
Bearish
TYK Medicines Wins Approval for Full H-Share Circulation in Hong Kong
TipRanks News
Neutral
TYK Medicines’ Lung Cancer Drug Asandeutertinib NDA Accepted by China’s NMPA
TipRanks News
Neutral
TYK Medicines’ Lung Cancer Drug Asandeutertinib Granted Priority Review in China
TipRanks News
Bullish
TYK Medicines Wins CSRC Nod for Conversion of 4.6 Million Unlisted Shares into H Shares
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:2410’s Media Buzz Sentiment?
Currently, no data Available
What is HK:2410’s weekly average amount of articles?
Currently, no data Available
What is HK:2410’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
ALLOAllogene Therapeutics
STAAStaar Surgical
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week